CMS Permanent Cardiac Pacemaker Coverage Policy Updated: What Billing Teams Need to Know (NCD 357)

The Centers for Medicare & Medicaid Services has issued a modification to National Coverage Determination 357, which governs Medicare coverage for single chamber and dual chamber permanent cardiac pacemakers. This update, effective March 12, 2026, clarifies both the covered and non-covered indications for pacemaker implantation — and the distinctions matter enormously for claims that reach Medicare adjudication. If your practice or facility bills for cardiac device implantation, this policy deserves a close review before the effective date.

What NCD 357 Covers: CMS Pacemaker Medical Necessity Criteria

CMS has determined that the evidence is sufficient to support coverage of implanted permanent cardiac pacemakers — both single chamber and dual chamber — when specific clinical conditions are met. The policy applies under three Medicare benefit categories: Inpatient Hospital Services, Physicians' Services, and Prosthetic Devices.

Coverage hinges on two nationally covered indications:

The word "documented" is doing real work here. CMS expects the medical record to clearly establish both the symptom burden and the non-reversible nature of the underlying condition. Symptoms of bradycardia are defined in the policy as those directly attributable to a heart rate under 60 beats per minute — including syncope, seizures, congestive heart failure, dizziness, and confusion.

Single chamber devices typically target either the right atrium or right ventricle. Dual chamber devices stimulate both the right atrium and right ventricle. The implantation procedure is performed under local anesthesia with brief hospitalization, and the device lead is threaded through a catheter to the appropriate cardiac chamber(s), with the pulse generator housed in a subcutaneous pocket on the upper chest wall.

12 Non-Covered Indications Under CMS NCD 357 — Know These Before You Bill

This is where denials happen. CMS explicitly lists 12 nationally non-covered indications under this NCD. Billing teams should treat this list as a denial risk checklist:

1. Reversible causes of bradycardia — including electrolyte abnormalities, medications or drugs, and hypothermia
2. Asymptomatic first degree AV block
3. Asymptomatic sinus bradycardia
4. Asymptomatic sino-atrial block or asymptomatic sinus arrest
5. Ineffective atrial contractions (e.g., chronic atrial fibrillation or flutter, or giant left atrium) without symptomatic bradycardia
6. Asymptomatic second degree AV block of Mobitz Type I — unless QRS complexes are prolonged or electrophysiological studies confirm the block is at or beyond the His Bundle
7. Syncope of undetermined cause
8. Bradycardia during sleep
9. Right bundle branch block with left axis deviation (and other fascicular or bundle branch block forms) without syncope or other symptoms of intermittent AV block
10. Asymptomatic bradycardia in post-MI patients about to begin long-term beta-blocker therapy
11. Frequent or persistent supraventricular tachycardias — except where the pacemaker is specifically for tachycardia control
12. Intermittent and brief pacing conditions not associated with a reasonable likelihood that pacing needs will become prolonged

Several of these are nuanced. Mobitz Type I AV block (Wenckebach), for instance, is generally non-covered — but electrophysiological study findings can shift that determination. Syncope of undetermined cause is explicitly excluded, which means documentation must connect the dots between the patient's symptoms and a confirmed, non-reversible bradycardia etiology before implantation.

How CMS Handles Indications Not Listed in NCD 357

Not every clinical scenario fits cleanly into the covered or non-covered buckets. For indications not specifically addressed in this NCD, CMS instructs Medicare Administrative Contractors (MACs) to make coverage determinations under Section 1862(a)(1)(A) of the Social Security Act — the "reasonable and necessary" standard.

This means your MAC has discretion for edge cases. If you're billing a pacemaker implant for an indication that falls outside the 12 non-covered conditions but isn't explicitly listed as covered, your best protection is airtight clinical documentation and a proactive check with your regional MAC's local coverage determination (LCD) library.

Affected Codes

This policy does not list specific CPT, HCPCS, or ICD-10 codes within NCD 357 as published. Billing teams should reference their MAC's associated LCDs and billing articles for procedure-level code guidance. Contact your MAC directly or consult CMS's Medicare Coverage Database for any associated code lists tied to this NCD.

What Your Billing Team Should Do